Morepen Laboratories

quarterly
yearly
ParticularsJun '22Sep '22Dec '22Mar '23Jun '23
Revenue303.31403.85349.69366.81403.46
Expenses295.00381.54335.69355.67382.94
EBITDA15.4629.7821.7418.6828.50
EBIT8.7022.7814.5511.7020.79
Profit Before Tax8.3122.3114.0011.1420.51
Net Profit5.6315.818.998.2414.63
Financial Ratios
Operating Profit Margin5.11%7.39%6.24%5.14%7.11%
Net Profit Margin1.86%3.92%2.58%2.27%3.65%
Earning Per Share (Diluted)0.110.330.160.160.29
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2023 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.3.2
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK MAHINDRA |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  BANDHAN |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  IDBI |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ |  BAJAJ